Latest Revenue Growth News

PolyNovo’s NovoSorb BTM, combined with negative pressure wound therapy, significantly accelerates healing of large post-surgical diabetic foot wounds, according to new clinical trial data.

4DMedical confirms its partnership with AstraZeneca in Brazil and announces a new contract supporting Australia’s National Lung Cancer Screening Program, signaling strategic growth in respiratory imaging.

IODM Limited reports a striking 227% year-on-year revenue surge in its UK Education segment for the first two months of FY26, signaling robust momentum ahead of a key invoicing period.

Stakk Limited has renewed its key contract with New York fintech Current Financial, locking in $280,000 in annual recurring revenue and reinforcing its foothold in the US embedded finance market.

Nanoveu Limited reveals significant progress in its ECS-DoT system-on-chip technology, showcasing a 60% average increase in drone flight endurance and advancing production with TSMC’s 16nm process. The company’s latest investor webinar highlights its growing OEM partnerships and disruptive edge AI capabilities.

AdNeo Limited has expanded its footprint in the vocational education sector by acquiring Aspire Learning Resources, adding valuable content and partnerships to its Catapult platform.

Elixinol Wellness has raised $2.5 million through a well-supported placement and appointed industry veteran Gavin Evans as strategic advisor to drive its next phase of growth and operational reset.

Rewardle Holdings reported a modest revenue increase for FY25 but saw its loss more than double, driven by investments in AI-powered MedTech associate CloudHolter and expanded platform initiatives.

Frontier Digital Ventures reported a 5% decline in revenue but a striking 71% jump in EBITDA for the first half of 2025, driven by margin expansion and operational efficiencies across its classifieds marketplaces in emerging regions.

Orthocell Limited reports an 81.1% overall treatment success rate from its Remplir Real World Evidence study, reinforcing the product’s safety and efficacy as it expands sales in the US and prepares regulatory submissions for the EU and UK.

Mayne Pharma has publicly refuted recent media claims about plans to close its Salisbury manufacturing site, clarifying its position amid ongoing regulatory scrutiny of its Scheme transaction with Cosette.

SenSen Networks has secured $2 million in new contracts across Singapore, the USA, and Australia, reinforcing its position as a leader in Live Awareness AI solutions. The company also strengthened its balance sheet with $1.5 million cash received from a recent Montreal project.